期刊文献+

一些营养素在肠易激综合征中的治疗作用及机制分析 被引量:4

THERAPEUTIC EFFECTS AND MECHANISMS OF SOME NUTRIENTS IN IRRITABLE BOWEL SYNDROME
原文传递
导出
摘要 肠易激综合征(irritable bowel syndrome,IBS)是一种全球多发的功能性胃肠道疾病,主要表现为腹痛和排便异常。IBS病理、生理机制复杂,临床治疗难度大。营养干预是IBS重要的治疗手段之一,能够明显改善患者的生活质量。本文就碳水化合物、长链多不饱和脂肪酸、膳食纤维及维生素D等多种营养功能成分对IBS的应用治疗效果及作用机制进行了综述,以期为IBS的临床营养治疗方案优化等提供参考。 Irritable bowel syndrome(IBS)is a prevalent functional gastrointestinal disorder worldwide and characterized mainly by abdominal pain and abnormal bowel movements.The pathological and physiological mechanisms of IBS are complex,making clinical treatment challenging.Dietary intervention is a common approach to treating IBS and significantly improving patients'quality of life.This article reviews the therapeutic effects and mechanisms of spome nutrients,such as carbohydrates,polyunsaturated fatty acids,dietary fiber,and vitamin D,in IBS,so as to provide a more reasonable dietary treatment plan for IBS patients.
作者 宋亦男 于海宁 沈生荣 SONG Yi-nan;YU Hai-ning;SHEN Sheng-rong(Zhejiang University of Technology,Hangzhou 310014;Zhejiang University,Hangzhou 310058,China)
出处 《营养学报》 CAS CSCD 北大核心 2024年第1期95-101,共7页 Acta Nutrimenta Sinica
关键词 肠易激综合征 营养 肠道菌群 炎症 irritable bowel syndrome nutrition intestinal microbiota inflammation
  • 相关文献

参考文献3

二级参考文献30

  • 1[1]Rigaud D,Cosnes J,Le Quintrec Y,Rene E,Gendre JP,Mignon M.Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease:elemental versus polymeric diet.Gut 1991;32:1492-1497
  • 2[2]Fell JM,Paintin M,Arnaud-Battandier F,Beattie RM,Hollis A,Kitching P,Donnet-Hughes A,MacDonald TT,Walker-Smith JA.Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease.Aliment Pharmacol Ther 2000;14:281-289
  • 3[3]Teahon K,Pearson M,Smith T,Bjarnason I.Alterations in nu tritional status and disease activity during treatment of Crohn's disease with elemental diet.Scand J Gastroenterol 1995;30:54-60
  • 4[4]Ligumsky M,Simon PL,Karmeli F,Rachmilewitz D.Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease.Gut 1990;31:686-689
  • 5[5]Dionne S,D'Agata ID,Hiscott J,Vanounou T,Seidman EG.Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).Clin Exp Immunol 1998;112:435-442
  • 6[6]Andus T,Daig R,Vogl D,Aschenbrenner E,Lock G,Hollerbach S,Kollinger M,Scholmerich J,Gross V.Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.Gut 1997;41:651-657
  • 7[7]Casini-Raggi V,Kam L,Chong YJ,Fiocchi C,Pizarro TT,Cominelli F.Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease.A novel mechanism of chronic intestinal inflammation.J Immunol 1995;154:2434-2440
  • 8[8]Grimble GK,Tappia PS.Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids.Zeitschrift fur Ernaehrungswissenschaft 1998;37:57-65
  • 9[9]Meydani SN,Dinarello CA.Influence of dietary fatty acids on cytokine production and its clinical implications.Nutr Clin Pract 1993;8:65-72
  • 10[10]Kremer JM.n-3 fatty acid supplements in rheumatoid arthritis.Am J Clin Nutr 2000;71:349S-351S

共引文献19

同被引文献89

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部